Pillstats
Rx only · Tablet, Film Coated · Oral

Glipizide And Metformin Hcl

Glipizide + Metformin Hydrochloride

3 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US7 NDCs
3 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)6809
US makers3 labelers
Packages12
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 6 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.070$0.140$0.210$0.280Dec 2025Apr 2026Jul 2026
$0.242
Latest avg · Jul 22, 2026
+3%
Since Dec 17, 2025
3
Active US suppliers
75%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

2.1K4.1K6.2K8.2K2025 Q12025 Q22025 Q32025 Q42026 Q1
3.6K
Rx · 2026 Q1
421K
Units dispensed
-50%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it3 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.unknown6SUPPLYING
Proficient Rx LPunknown3SUPPLYING
Chartwell RX, LLCunknown3SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Mar 25, 2015
    RECALLRecall (Class II): GLIPIZIDE and METFORMIN HYDROCHLORIDE Tablets, USP, 2.5 mg/500 mg, 100 ct Bottles, Rx Only. Manufactured for: Heritage…

    Failed Impurities/Degradation Specifications: Out of specification for unknown impurity. — Recalling firm: Heritage Pharmaceuticals, Inc. — U.S. Nationwide including Puerto Rico.